Skip to main content

Published locations for ASH: First-line ibrutinib beats standard chemo for CLL/SLL in older patients

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. ASH: First-line ibrutinib beats standard chemo for CLL/SLL in older patients

User login

  • Reset your password
  • /content/ash-first-line-ibrutinib-beats-standard-chemo-cll/sll-older-patients
  • /hematologynews/article/104952/cll/ash-first-line-ibrutinib-beats-standard-chemo-cll/sll-older
  • /oncologypractice/article/104952/cll/ash-first-line-ibrutinib-beats-standard-chemo-cll/sll-older
  • /hematology-oncology/article/104952/cll/ash-first-line-ibrutinib-beats-standard-chemo-cll/sll-older
  • /b-cell-lymphoma-icymi/article/104952/cll/ash-first-line-ibrutinib-beats-standard-chemo-cll/sll-older